机构:[a]Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, PR China深圳市第二人民医院深圳医学信息中心[b]School of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan, PR China[c]Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, PR China[d]Department of Medical Imageology, North Sichuan Medical College, Nanchong, Sichuan, PR China[e]Department of Pathology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China
the Project from Nanchong
Science and Technology Project (19SXHZ0330, 18SXHZ0101),
the Youth Project of Basic and Applied Basic Research Fund from
Joint Guangdong-Shenzhen Funds (2019A1515110565) and the
Innovation and Entrepreneurship Training Program for College
Students of China (201910634024).
第一作者机构:[a]Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, PR China
共同第一作者:
通讯作者:
通讯机构:[a]Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, PR China[b]School of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan, PR China[*1]Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, No. 3002 Sungang Xi Road, Futian District, Shenzhen, Guangdong, 518035, PR China.[*2]School of Basic Medicine, North Sichuan Medical College, No. 55 Dongshun Road, Gaoping District, Nanchong, Sichuan, 637000, PR China
推荐引用方式(GB/T 7714):
Yonggang Ren,Yi Zhang,Jialing Liu,et al.Matrix hardness regulates the cancer cell malignant progression through cytoskeletal network.[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2021,541:95-101.doi:10.1016/j.bbrc.2021.01.014.
APA:
Yonggang Ren,Yi Zhang,Jialing Liu,Peiru Liu,Jing Yang...&Jia Tao.(2021).Matrix hardness regulates the cancer cell malignant progression through cytoskeletal network..BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,541,
MLA:
Yonggang Ren,et al."Matrix hardness regulates the cancer cell malignant progression through cytoskeletal network.".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 541.(2021):95-101